-The Times of India MUMBAI: The Union government and regulatory bodies appear to be serious in ending the pharma-doctor nexus and curb unethical marketing practices. In its latest effort, the Medical Council of India has directed doctors, hospitals and medical colleges to prescribe generic medicines as far as possible. Generic medicines are more affordable versions of branded medicines sold by companies. In its directive dated January 21 to the principals of medical...
More »SEARCH RESULT
How We Saved Agriculture, Fed the World and Ended Rural Poverty: Looking Back from 2050 -Duncan Green
-Oxfam Blog As Oxfam’s two week online debate on the future of agriculture gets under way, John Ambler of Oxfam America imagines how it could all turn out right in the end. It is now 2050. Globally, we are 9 billion strong. Only 20% of us are directly involved in agriculture, and poor country economies have diversified. Yet we all have enough food. Technological innovation has played its part, but increased production...
More »Growing crisis of drug prices
-The Hindu India’s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price...
More »Focus on spurious, substandard drugs is more important
-The Economic Times The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well,...
More »SC to Examine New Drug Pricing Policy
-Outlook The Supreme Court today said it would examine the National Pharmaceutical Pricing Policy after it is notified with the Centre promising to do it within two weeks. A bench headed by Justice G S Singhvi granted two weeks time to the Centre to issue notification and posted the matter for hearing on December 12. Additional Solicitor General Siddharth Luthra informed the court that the Cabinet had approved the policy that will bring...
More »